Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 15 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8828996

    Morpholine-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  2. US 8829007

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  3. US 8829204

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  4. US 8822451

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  5. US 8822469

    Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  6. US 8822681

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  7. US 8815866

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  8. US 8809335

    Pyrazolopyrimidine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  9. US 8809353

    Quinazolines useful as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  10. US 8802700

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  11. US 8802844

    Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  12. US 8802868

    Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  13. US 8796308

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  14. US 8796453

    Processes and intermediates for producing azaindoles

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  15. US 8796312

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  16. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  17. US 8785476

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  18. US 8785640

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  19. US 8779156

    Analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  20. US 8779197

    Aryl amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  21. US 8779127

    Processes for preparing substituted pyrimidines

    Vertex Pharmaceuticals Incorporated · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  22. US 8765731

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  23. US 8765957

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  24. US 8765751

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted